We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:BBIO

BridgeBio Pharma (BBIO)

Nasdaq • BBIO • US10806X1028

74.29Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 12.3% of free float sold short, 7.7 days to cover, cost to borrow 0.51%. Sign up for live short interest data.

Market Cap

14.5b USD | # 1248 in US

Volume

2.71m shares | 196.22m USD

Shares Outstanding

194.8m

Free Float Shares

85.48% | 166.51m

DB:2CL|

XTRA:2CL|

News

BBIO key data

BridgeBio Pharma (Nasdaq: BBIO) has a market capitalization of $14.47B. Last close $74.29 (as of 2026-11-09); 52-week range $62.06 to $93.42. ORTEX data as of 2026-10-22: short interest was 12.29% of free float, 7.7 days to cover and the average cost to borrow was 0.51%. Sign up for live short interest data.

Latest on BBIO

Aug 10, 2026BridgeBio Heads Into Results With Bulls Dominating the Options Tape

All BBIO news on ORTEX News

BBIO news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.